MedTrace Logo

Patient-Reported Outcome Study of Project ECHO for ILD

NCT05450276 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2022-07-08

No results posted yet for this study

Summary

The study will assess whether patients of providers participating in Project ECHO for ILD experience reduced stress, including financial stress, based on their ability to receive timely and local care and services, The study will employ nested mixed-method design at baseline, at 6 months and at 12 months to answer the study question.

Conditions

Sponsors & Collaborators

  • Genentech, Inc.

    collaborator INDUSTRY

  • Pulmonary Care and Research Collaborative Limited

    lead OTHER

Principal Investigators

  • Aliaa Barakat, PhD · Pulmonary Care and Research Collaborative, Ltd.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2023-12-31
Completion
2024-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05450276 on ClinicalTrials.gov